Morris Udall Parkinson's Disease Research Center of Excellence, University of Virginia, Charlottesville, VA, United States.
Mitochondrion. 2011 Jan;11(1):108-18. doi: 10.1016/j.mito.2010.08.004. Epub 2010 Aug 18.
Recombinant human mitochondrial transcription factor A protein (rhTFAM) was evaluated for its acute effects on cultured cells and chronic effects in mice. Fibroblasts incubated with rhTFAM acutely increased respiration in a chloramphenicol-sensitive manner. SH-SY5Y cells showed rhTFAM concentration-dependent reduction of methylpyridinium (MPP(+))-induced oxidative stress and increases in lowered ATP levels and viability. Mice treated with weekly i.v. rhTFAM showed increased mitochondrial gene copy number, complex I protein levels and ATP production rates; oxidative damage to proteins was decreased ~50%. rhTFAM treatment improved motor recovery rate after treatment with MPTP and dose-dependently improved survival in the lipopolysaccharide model of endotoxin sepsis.
重组人线粒体转录因子 A 蛋白 (rhTFAM) 已被评估其对培养细胞的急性作用和对小鼠的慢性作用。与 rhTFAM 孵育的成纤维细胞可迅速以氯霉素敏感的方式增加呼吸作用。SH-SY5Y 细胞表现出 rhTFAM 浓度依赖性降低甲基吡啶鎓 (MPP(+)) 诱导的氧化应激和降低的 ATP 水平和活力增加。每周静脉注射 rhTFAM 的小鼠表现出线粒体基因拷贝数增加,复合物 I 蛋白水平和 ATP 产生速率增加;蛋白质的氧化损伤减少了约 50%。rhTFAM 治疗可改善 MPTP 治疗后的运动恢复率,并在脂多糖内毒素败血症模型中剂量依赖性地改善生存。